Dr. Gosiewska is a leading expert in regenerative medicine. She received her PhD in Medical Biology from Medical University of Bialystok, Poland. She conducted her postdoctoral studies of cell-extracellular matrix interactions at the National Institutes of Health (Bethesda, Maryland). In 2020, after 25 years of focusing on cell therapy and regenerative medicine at Johnson & Johnson Inc., she joined Celularity Inc., as Vice President R&D, Degenerative Diseases to drive strategy and product development based on placental-derived biomaterials and cells. Anna has published many research articles and has 122 patent applications. She is a member of several international scientific societies.